The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Understanding real-world treatment and outcomes in patients diagnosed with metastatic triple negative breast cancer (mTNBC).
 
Karen E Skinner
Research Funding - AstraZeneca (Inst); Merck (Inst)
 
Mark S. Walker
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Celgene (Inst); Eisai (Inst); Genentech (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst)
 
Amin Haiderali
Employment - Merck
Stock and Other Ownership Interests - GlaxoSmithKline; Merck
Travel, Accommodations, Expenses - Merck
Other Relationship - Merck
 
Lee Steven Schwartzberg
Honoraria - Amgen; NanoString Technologies; Novartis; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; Caris Life Sciences; Genomic Health; Helsinn Therapeutics; Pfizer; Spectrum Pharmaceuticals; Tesaro